These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35280)

  • 21. Mutagenicity of amine drugs and their products of nitrosation.
    Andrews AW; Lijinsky W; Snyder SW
    Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of nitrosamines to mutagens by rat and rabbit nasal, lung and liver S-9 homogenates.
    Dahl AR
    Adv Exp Med Biol; 1986; 197():367-72. PubMed ID: 2945408
    [No Abstract]   [Full Text] [Related]  

  • 23. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    Mutat Res; 1981 Jan; 80(1):1-7. PubMed ID: 7010130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Denda A; Konishi Y
    Carcinogenesis; 1986 Mar; 7(3):375-9. PubMed ID: 3512116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsome-mediated mutagenesis in V79 Chinese hamster cells by various nitrosamines.
    Kuroki T; Drevon C; Montesano R
    Cancer Res; 1977 Apr; 37(4):1044-50. PubMed ID: 321116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative mutagenicity of N-nitrosamines in a semi-solid and in a liquid incubation system in the presence of rat or human tissue fractions.
    Bartsch H; Camus A; Malaveille C
    Mutat Res; 1976 Nov; 37(2-3):149-62. PubMed ID: 794701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of some dialkylnitrosamines, cyclic nitrosamines and N,N-diethanolnitrosamine in Salmonella typhimurium with rat and rabbit nasal, lung and liver S9 homogenates.
    Dahl AR
    Mutat Res; 1985 Dec; 158(3):141-7. PubMed ID: 3908927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.
    Eisenbrand G; Denkel E; Pool B
    J Cancer Res Clin Oncol; 1984; 108(1):76-80. PubMed ID: 6378917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenicity of carcinogenic azo dyes and their derivatives.
    Yahagi T; Degawa M; Seino Y; Matsushima T; Nagao M
    Cancer Lett; 1975 Nov; 1(2):91-6. PubMed ID: 828073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenicity of aliphatic nitrosamines in Salmonella typhimurium.
    Rao TK; Young JA; Lijinsky W; Epler JL
    Mutat Res; 1979 Jan; 66(1):1-7. PubMed ID: 370582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and mutagenicity of 4-(N-butylnitrosamino)-4-hydroxybutyric acid lactone, a possible activated metabolite of the proximate bladder carcinogen N-butyl-N-(3-carboxypropyl)nitrosamine.
    Mochizuki M; Irving CC; Anjo T; Wakabayashi Y; Suzuki E; Okada M
    Cancer Res; 1980 Jan; 40(1):162-5. PubMed ID: 6765916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
    Czygan P; Greim H; Garro A; Schaffner F; Popper H
    Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutagenicity and rat-liver S9 demethylation kinetics of N-nitrosomethylaniline and its ring-substituted derivatives.
    Kroeger-Koepke MB; Andrews AW; Kupper RJ; Koepke SR; Michejda CJ
    Mutat Res; 1981 Aug; 89(4):255-67. PubMed ID: 7027031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity of 22 N-nitrosamides and related compounds for Salmonella typhimurium TA1535.
    Lee K; Gold B; Mirvish SS
    Mutat Res; 1977 Apr; 48(2):131-8. PubMed ID: 17832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of mutagenic activity of ticlopidine in the Ames Salmonella/microsome test.
    Hannuniemi R; Sellman R
    Mutat Res; 1985; 158(1-2):31-3. PubMed ID: 3900717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity of N-nitrosopyrrolidine derivatives in Salmonella (Ames) and Escherichia coli K-12 (343/113) assays.
    Rao TK; Cox JT; Allen BE; Epler JL; Lijinsky W
    Mutat Res; 1981 May; 89(1):35-43. PubMed ID: 7017389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivatives.
    Frei E; Pool BL; Plesch W; Wiessler M
    IARC Sci Publ; 1984; (57):491-7. PubMed ID: 6398301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.